Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1766 of 6351
-
Weight-Loss drug liraglutide tested in kids as young as 6
Disease control OngoingThis randomized controlled trial evaluates the efficacy, safety, metabolic, and cardiovascular effects of liraglutide in children aged 6 to 12 years with severe obesity. Participants are randomized to receive liraglutide plus lifestyle intervention or lifestyle intervention alone…
Phase 4 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Radioactive drug shows promise in High-Risk prostate cancer before surgery
Disease control Recruiting nowTo learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. Phase 2 will open if the Phase 1 dose is found to be safe. To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androgen deprivation therapy (ADT) on patients with high-risk, localized prostate canc…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New pill could tame stubborn ulcerative colitis
Disease control OngoingThe main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The partici…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New registry tracks PRRT outcomes for neuroendocrine cancer patients
Disease control Recruiting nowThe specific aim is of this study is to gain a better understanding of the patient characteristics, treatment responses, survival outcomes, and adverse events associated with PRRT in patients with gastroenteropancreatic primary NETs.
Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Can magnetic pulses sharpen aging brains? new trial aims to find out.
Knowledge-focused Recruiting nowThe proposed research will use closed-loop transcranial magnetic stimulation (TMS) based on individualized brain networks to establish parameters that can reliably control brain states. This will be tested in healthy aging and mild cognitive impairment (MCI) cohorts. The investig…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Could a 3-Day pill ease severe postpartum depression?
Symptom relief CompletedThe purpose of this research study is to test the study drug, NORA520, as a possible treatment for severe postpartum depression (PPD). The trial aims to determine: * How well NORA520 is tolerated and what side effects it may cause * If NORA520 reduces depressive symptoms in subj…
Phase 2 • Sponsor: TWi Biotechnology, Inc. • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
New vaginal insert aims to clear persistent HPV in women
Disease control CompletedThis is a blinded study to assess safety, tolerability, and efficacy of ABI-2280 vaginal inserts in participants diagnosed with persistent cervical hrHPV infection. This study will have up to 11 cohorts with various dose strengths and regimens. Each cohort will start with a senti…
Phase 1/2 • Sponsor: Antiva Biosciences • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a phone app boost HIV prevention in rural america?
Prevention OngoingThe goal of this clinical trial is to test the efficacy of a mobile app, Combine, to increase the uptake of HIV and STI testing and pre-exposure prophylaxis (PrEP) over 24 months and to assess the effects of different implementation strategies on intervention maintenance among GB…
Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
New pill could ease ulcerative colitis Flare-Ups
Disease control OngoingThe goal of this study is to learn if emvistegrast (formerly GS-1427) is effective in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with emvistegrast with participants treated with place…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Genetically modified NK cells take on rare sarcomas in early trial
Disease control Recruiting nowThe goal of this clinical research study is to find a recommended dose of donated NK cells that can be given along with chemotherapy to patients with advanced cancers. The safety and effects of this therapy will also be studied.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Speedy gene test aims to give answers on birth defects in just 7 days
Knowledge-focused CompletedThe management of congenital malformations (3% of pregnancies) by prenatal ultrasound represents a real medical challenge. Their prognosis is variable depending on the underlying aetiology. In France, prenatal diagnosis (PND) has long been based on imaging or infectious, metaboli…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New rotavirus vaccine passes first safety check in early trial
Vaccine CompletedThe Phase I clinical trial of the oral hexavalent reassortant rotavirus attenuated live vaccine (Vero Cells) will be conducted in a population ranging from 6 weeks to 59 years of age. The objective of this study is to evaluate the safety of investigational vaccine in healthy adu…
Phase 1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 11:03 UTC
-
New depression pill shows promise in early trial
Symptom relief CompletedThis study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did not work. The purpose of the study is to find out whether a medicine called BI 1569912 helps people with depression. Participants …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Poop pills could tame rare liver disease
Disease control Recruiting nowFARGO is a randomised, phase IIa, multi-centre, placebo-controlled trial to compare Faecal Microbiota Transplant (FMT) with placebo in patients with primary sclerosing cholangitis (PSC) and concomitant inflammatory bowel disease.
Phase 2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Bladder cancer diagnosis: could a simple MRI replace painful biopsies?
Diagnosis Recruiting nowThis is a pilot, single arm, prospective study that aims to validate the accuracy of the VI-RADS score obtained via multi-parametric magnetic resonance imaging (mpMRI) compared to pathologic cancer stage obtained via diagnostic transurethral bladder tumor resection (TURBT) as wel…
Sponsor: University of California, Irvine • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New migraine drug shows promise in Real-World study
Disease control CompletedThe purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of eptinezumab as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill taken every other day could prevent migraines
Disease control Recruiting nowThe purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a steroid injection before root canal silence Post-Procedure pain?
Symptom relief CompletedThe aim of this randomized clinical trial to evaluate the effect of dexamethasone in two different techniques on postoperative pain by dividing patients randomly into three groups: * Group I: buccinator injection of dexamethasone. * Group II: buccal infiltration of dexamethasone…
Phase 4 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New daily pill shows promise for Hard-to-Treat leukemia
Disease control Recruiting nowThe goal of the study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of TERN-701, a highly selective allosteric inhibitor of BCR-ABL1, in participants with previously treated chronic phase - chronic myeloid leukemia (CP-CML). The study h…
Phase 1/2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can switching meds or using E-Cigs help smokers quit for good?
Disease control Recruiting nowThis is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicli…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC